Form 4 Filing for AVANOS MEDICAL, INC.

Scott Michael Galovan, SVP and Chief Financial Officer of AVANOS MEDICAL, INC., reported a disposition of 4,428 shares of Common Stock on April 22, 2026. This transaction was a result of shares surrendered to satisfy tax withholding obligations upon the vesting of 12,225 time-based restricted share units. The shares were acquired on April 22, 2025, and vested on April 22, 2026. Following this transaction, Mr. Galovan holds 135,596 shares of Common Stock directly. The price per share in this transaction was $24.64.